A Study of Personalized Neoantigen Cancer Vaccines

Clinical trial NCT03794128 · COMPLETED

Trial details

NCT number: NCT03794128
Sponsor: Gritstone bio, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Colorectal Cancer Gastroesophageal Adenocarcinoma Urothelial Carcinoma Pancreatic Ductal Adenocarcinoma

Start date: 2018-07-25
Primary completion: 2020-01-17
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.